Alnylam Pharmaceuticals
ALNY
#565
Rank
โ‚ฌ33.70 B
Marketcap
260,37ย โ‚ฌ
Share price
-3.35%
Change (1 day)
85.57%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company